RxDoctor Payments Data

Matthew Yoak, MD

Plastic and Reconstructive Surgery · Marietta, OHNPI 1922003219

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 24.5% of the total. Reporting peaked in 2019 at $297 and has fallen 91.3% since, to $26 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OH, where the typical reported total is $1,639.

$451in general payments, 2019–2025

Across 17 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$110
  • Misonix Inc$82
  • Mentor Worldwide LLC$72
  • Teva Pharmaceuticals USA, Inc.$49
  • Bioventus LLC$34
  • Smith+Nephew$26
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$451100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$451 in reported general payments places this provider in the 25th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$100,596
Medicare patients
166
Services billed
508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen109$546
Cephalexin16$73

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Marietta

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →